Stay updated on HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial
Sign up to get notified when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.

Latest updates to the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedNew version 3.3.2 was added on 2025-11-20 with an updated Study Status; the prior revision v3.2.0 is removed.SummaryDifference0.2%

- Check19 days agoChange DetectedRemoved the government funding lapse disclaimer that used to appear on the page; its removal does not affect the study data, status details, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check26 days agoChange DetectedRecord History was updated with a new 2025-11-05 entry adding Contacts/Locations and Study Status (version 66), and an older 2025-10-21 entry was removed.SummaryDifference0.2%

- Check40 days agoChange DetectedNew record versions 63–65 appear, showing updated Study Status and a Results Submission event, along with related QC notes. These entries reflect the latest updates to the trial's record history.SummaryDifference0.1%

- Check62 days agoChange DetectedNew study status sections and a v3.2.0 revision are added, along with a government-operating-status notice; the old v3.1.0 revision is removed.SummaryDifference11%

- Check69 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.